U.S. Food and Drug Administration
Massachusetts Addiction Specialist to Administer New FDA Approved VIVITROL(R) at 37 Clinical Locations across the State
Published in Drug Week, November 5th, 2010
Punyamurtula S. Kishore MD, MPH, FASAM, of Preventive Medicine Associates, Inc. (PMAI), the largest outpatient substance dependence provider in Massachusetts, announced his 37 clinical locations will be offering new addiction treatment options through the use of VIVITROL® (naltrexone for extended-release injectable suspension), which was approved on Tuesday, October 12, 2010 by the U.S. Food and Drug Administration (FDA) for the prevention of relapse to opioid dependence.
Dr. Kishore and PMAI have been leading the charge with the use of VIVITROL since 2006, when it was first approved for the treatment for alcohol dependence. With new FDA approval, the once-monthly...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2010-11-05)
More Articles from Drug Week
- Managed Care
Colombia's Public Sectors Share of Total Healthcare Expenditure Will Fall Significantly From 96.4% in 2009 To 68.7% by 2014 - Heparin Therapy
Data from R. Harris and colleagues advance knowledge in heparin therapy - Platinum Compounds
Data on platinum compounds reported by researchers at Chinese University of Hong Kong - Polyethylenes
Data on polyethylenes published by D. Palmer and colleagues - Business News
Emergency Physicians Urge Americans to Take The American Medicine Chest Challenge November 13th - Antibiotics
Findings from Enanta Pharmaceuticals, Inc. provide new insights into antibiotics - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
